Form 8-K - Current report:
SEC Accession No. 0001193125-26-232707
Filing Date
2026-05-20
Accepted
2026-05-20 16:30:32
Documents
22
Period of Report
2026-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d148580d8k.htm   iXBRL 8-K 53287
2 EX-1.1 d148580dex11.htm EX-1.1 287280
3 EX-4.3 d148580dex43.htm EX-4.3 250161
4 EX-4.4 d148580dex44.htm EX-4.4 154947
5 EX-5.1 d148580dex51.htm EX-5.1 15854
6 EX-5.2 d148580dex52.htm EX-5.2 13052
11 GRAPHIC g148580g0515104601444.jpg GRAPHIC 3949
12 GRAPHIC g148580g0519044356496.jpg GRAPHIC 2410
13 GRAPHIC g148580g0519094107261.jpg GRAPHIC 4668
14 GRAPHIC g148580g48x20.jpg GRAPHIC 3668
15 GRAPHIC g148580g88l18.jpg GRAPHIC 4168
  Complete submission text file 0001193125-26-232707.txt   1170543

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lly-20260520.xsd EX-101.SCH 6048
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20260520_def.xml EX-101.DEF 16099
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20260520_lab.xml EX-101.LAB 27713
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20260520_pre.xml EX-101.PRE 17521
26 EXTRACTED XBRL INSTANCE DOCUMENT d148580d8k_htm.xml XML 14726
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 261004476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)